ATLCAR.CD138

ATLCAR.CD138 CAR-T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATLCAR.CD138, covering 2025-09-16 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma [Phase 1]